Patents by Inventor Timothy F. Gallagher
Timothy F. Gallagher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11912545Abstract: A wireless hoist system including a first hoist device having a first motor and a first wireless transceiver and a second hoist device having a second motor and a second wireless transceiver. The wireless hoist system includes a controller in wireless communication with the first wireless transceiver and the second wireless. The controller is configured to receive a user input and determine a first operation parameter and a second operation parameter based on the user input. The controller is also configured to provide, wirelessly, a first control signal indicative of the first operation parameter to the first hoist device and provide, wirelessly, a second control signal indicative of the second operation parameter to the second hoist device. The first hoist device operates based on the first control signal and the second hoist device operates based on the second control signal.Type: GrantFiled: June 26, 2020Date of Patent: February 27, 2024Assignee: Milwaukee Electric Tool CorporationInventors: Matthew Post, Gareth Mueckl, Matthew N. Thurin, Joshua D. Widder, Timothy J. Bartlett, Patrick D. Gallagher, Jarrod P. Kotes, Karly M. Schober, Kenneth W. Wolf, Terry L. Timmons, Mallory L. Marksteiner, Jonathan L. Lambert, Ryan A. Spiering, Jeremy R. Ebner, Benjamin A. Smith, James Wekwert, Brandon L. Yahr, Troy C. Thorson, Connor P. Sprague, John E. Koller, Evan M. Glanzer, John S. Scott, William F. Chapman, III, Timothy R. Obermann
-
Patent number: 10298588Abstract: A secure communication system comprises a software program client operating on a host computing device, a service manager configured to manage client access to the protected services, an authorizer in communication between the client and the service manager, and a receiver in communication with the service manager and serves as an interface to the protected services. At least one of a browser and an application of the client is configured to access one or more protected services running on a computing device that is remote to the host computing device over a communication channel. The service manager maintains a list of predetermined services authorized for the client and limits client access to the predetermined services.Type: GrantFiled: July 29, 2015Date of Patent: May 21, 2019Assignee: BlackSands, Inc.Inventors: Dan T. Pawl, Nathan J. Pawl, Timothy F. Gallagher
-
Publication number: 20170230374Abstract: A secure communication system comprises a software program client operating on a host computing device, a service manager configured to manage client access to the protected services, an authorizer in communication between the client and the service manager, and a receiver in communication with the service manager and serves as an interface to the protected services. At least one of a browser and an application of the client is configured to access one or more protected services running on a computing device that is remote to the host computing device over a communication channel. The service manager maintains a list of predetermined services authorized for the client and limits client access to the predetermined services.Type: ApplicationFiled: July 29, 2015Publication date: August 10, 2017Inventors: Dan T. Pawl, Nathan J. Pawl, Timothy F. Gallagher
-
Patent number: 7612075Abstract: This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa.Type: GrantFiled: July 25, 2003Date of Patent: November 3, 2009Assignee: Aventis Pharmaceuticals Inc.Inventors: William R. Ewing, Michael R. Becker, Yong Mi Choi-Sledeski, Heinz W. Pauls, Wei He, Stephen M. Condon, Roderick S. Davis, Barbara A. Hanney, Alfred P. Spada, Christopher J. Burns, John Z. Jiang, Michael R. Myers, Wan F. Lau, Aiwen Li, Gregory B. Poli, Mark A. Bobko, Robert L. Morris, Joseph M. Karpinski, Timothy F. Gallagher, Kent W. Neuenschwander, Robert D. Groneberg, Jean-Francois Sabuco
-
Patent number: 7091204Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.Type: GrantFiled: May 7, 2002Date of Patent: August 15, 2006Assignee: SmithKline Beecham CorporationInventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
-
Patent number: 7026349Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.Type: GrantFiled: May 7, 2002Date of Patent: April 11, 2006Assignee: SmithKline Beecham CorporationInventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
-
Patent number: 6849635Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.Type: GrantFiled: May 7, 2002Date of Patent: February 1, 2005Assignee: SmithKline Beecham CorporationInventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight, Stanley J. Schmidt
-
Publication number: 20040198979Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.Type: ApplicationFiled: November 7, 2003Publication date: October 7, 2004Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
-
Publication number: 20040152906Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.Type: ApplicationFiled: November 7, 2003Publication date: August 5, 2004Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
-
Publication number: 20040152891Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.Type: ApplicationFiled: November 7, 2003Publication date: August 5, 2004Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
-
Publication number: 20040152895Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.Type: ApplicationFiled: November 7, 2003Publication date: August 5, 2004Inventors: Dashyant Dhanak, Timothy F Gallagher, Steven D Knight, Stanley J Schmidt
-
Publication number: 20040152893Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.Type: ApplicationFiled: November 7, 2003Publication date: August 5, 2004Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D Knight, Stanley J. Schmidt
-
Publication number: 20040142948Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.Type: ApplicationFiled: November 7, 2003Publication date: July 22, 2004Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
-
Publication number: 20040102450Abstract: This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa..Type: ApplicationFiled: July 25, 2003Publication date: May 27, 2004Applicant: AVENTIS PHARMACEUTICALS INC.Inventors: William R. Ewing, Michael R. Becker, Yong Mi Choi-Sledeski, Heinz W. Pauls, Wei He, Stephen M. Condon, Roderick S. Davis, Barbara A. Hanney, Alfred P. Spada, Christopher J. Burns, John Z. Jiang, Aiwen Li, Michael R. Myers, Wan F. Lau, Gregory B. Poli, Mark A. Bobko, Robert L. Morris, Joseph M. Karpinski, Timothy F. Gallagher, Kent W. Neuenschwander, Robert D. Groneberg, Jean-Francois Sabuco
-
Publication number: 20030153604Abstract: This invention is directed to an (aminoiminomethyl or aminomethyl)benzoheteroaryl compound of formula I which is useful for inhibiting the activity of Factor Xa by combining said compound with a composition containing Factor Xa. The present invention is also directed to compositions containing compounds of the formula I, methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.Type: ApplicationFiled: February 24, 2003Publication date: August 14, 2003Applicant: Aventis Pharmaceuticals Inc.Inventors: William P. Dankulich, Daniel G. McGarry, Christopher Burns, Timothy F. Gallagher, Francis A. Volz
-
Patent number: 6541505Abstract: This invention is directed to an (aminoiminomethyl or aminomethyl)benzoheteroaryl compound of formula I which is useful for inhibiting the activity of Factor Xa by combining said compound with a composition containing Factor Xa. The present invention is also directed to compositions containing compounds of the formula I, methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.Type: GrantFiled: June 30, 2000Date of Patent: April 1, 2003Assignee: Aventis Pharmaceuticals Inc.Inventors: William P. Dankulich, Daniel G. McGarry, Christopher Burns, Timothy F. Gallagher, Francis A. Volz
-
Patent number: 6528512Abstract: This invention relates to the novel amino substituted pyrimidine compounds of Formulas (I), (II) and (III), and pharmaceutical compositions comprising a compound of these Formulas and a pharmaceutically acceptable diluent or carrier. This invention also relates to a method of inhibiting CSBP kinase and cytokines mediated by this kinase, for the treatment of cytokine mediated diseases, in mammals, by administration of a compound of Formula (I), (II) or (III).Type: GrantFiled: June 26, 2000Date of Patent: March 4, 2003Assignee: SmithKline Beecham CorporationInventors: Timothy F. Gallagher, Susan M. Thompson
-
Patent number: 6361773Abstract: This invention relates to drug binding proteins, to genes encoding same and to assays and methods for screening pharmaceuticals. More specifically, this invention relates to a Cytokine Suppressive Anti-Inflammatory Drug (CSAID) binding protein, to a gene encoding same and to assays and screens useful in the evaluation and characterization of drugs of this pharmacologic class.Type: GrantFiled: October 1, 1997Date of Patent: March 26, 2002Assignee: SmithKline Beecham CorporationInventors: John C. Lee, Jerry L. Adams, Timothy F. Gallagher, David W. Green, John Richard Heys, Peter C. McDonnell, Dean E. McNulty, Peter R. Young, James E. Strickler
-
Patent number: 6096748Abstract: This invention relates to the novel amino substituted pyrimidine compounds of Formulas (I), (II) and (III), and pharmaceutical compositions comprising a compound of these Formulas and a pharmaceutically acceptable diluent or carrier.This invention also relates to a method of inhibiting CSBP kinase and cytokines mediated by this kinase, for the treatment of cytokine mediated diseases, in mammals, by administration of a compound of Formula (I), (II) or (III).Type: GrantFiled: September 14, 1998Date of Patent: August 1, 2000Assignee: SmithKline Beecham CorporationInventors: Timothy F. Gallagher, Susan M. Thompson
-
Patent number: 5955366Abstract: This invention relates to drug binding proteins, to genes encoding same and to assays and methods for screening pharmaceuticals. More specifically, this invention relates to a Cytokine Suppressive Anti-Inflammatory Drug (CSAID) binding protein, to a gene encoding same and to assays and screens useful in the evaluation and characterization of drugs of this pharmacologic class.Type: GrantFiled: October 14, 1997Date of Patent: September 21, 1999Assignee: SmithKline Beecham CorporationInventors: John C. Lee, Jerry L. Adams, Timothy F. Gallagher, David W. Green, John Richard Heys, Peter C. McDonnell, Dean E. McNulty, James E. Strickler, Peter R. Young